Evidence map›Paper›PMID 32665015›Full record

ArticlePediatric rheumatology online journal2020

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission.

Inmaculada Concepción Aranda-Valera, Iván Arias de la Rosa, Rosa Roldán-Molina, María Del Carmen Ábalos-Aguilera, Carmen Torres-Granados, Alejandra Patiño-Trives, María Luque-Tevar, Alejandro Ibáñez-Costa, Rocío Guzmán-Ruiz, María Del Mar Malagón and 4 more

Open access · goldAbstract read
In one paragraph

Article in Pediatric rheumatology online journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Inmaculada Concepción Aranda-ValeraRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Iván Arias de la RosaRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Rosa Roldán-MolinaRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
María Del Carmen Ábalos-AguileraRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Carmen Torres-GranadosRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Alejandra Patiño-TrivesRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
María Luque-TevarRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Alejandro Ibáñez-CostaRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Rocío Guzmán-RuizDepartment of Cell Biology, Physiology and Immunology, IMIBIC, Reina Sofía University Hospital, University of Córdoba, Cordoba, Spain.
María Del Mar MalagónDepartment of Cell Biology, Physiology and Immunology, IMIBIC, Reina Sofía University Hospital, University of Córdoba, Cordoba, Spain.
Alejandro Escudero-ContrerasRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Chary López-PedreraRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Eduardo Collantes-EstévezRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain.
Nuria BarbarrojaRheumatology Department, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Cordoba, Spain. barbarrojan@gmail.com.ORCID http://orcid.org/0000-0002-0962-6072
Instituto Maimónides de Investigación Biomédica de Córdoba · ESInstituto de Salud Carlos III · ES

Funding

Spanish Society of Pediatric Rheumatology Moving4 grant
6 · The paper itself

Abstract

backgroundJuvenile Idiopathic Arthritis (JIA) is one of the most common chronic diseases of childhood that often persists into adulthood and can result in significant long-term morbidity. As a long lasting chronic inflammatory disease, concern has been raised regarding the risk of premature development of cardiovascular disease (CVD) in JIA. This study aims to determine whether adults with JIA in clinical remission display clinical and subclinical signs of CVD risk: inflammatory mediators, adipokines, endothelial dysfunction and oxidative stress markers.

methodsThis is a cross-sectional study including 25 patients diagnosed with JIA according to the International League of Associations for Rheumatology criteria (ILAR 2001) and 25 age- and sex-matched controls. Remission was determined by JADAS10 < 1 and according to Wallace criteria. The presence of traditional CVD risk factors was analyzed. An extensive clinical analysis including body mass index (BMI), lipid profile, homeostatic model assessment - insulin resistance (HOMA-IR) and arterial blood pressure was performed. Intima media thickness of the common carotid artery (CIMT) was measured as a marker of subclinical atherosclerosis. Several proinflammatory cytokines, molecules involved in the endothelial dysfunction, oxidative stress and adipokines were quantified on serum by ELISA and on peripheral blood mononuclear cells (PBMCs) by RT-PCR. In vitro studies were carried out in healthy PBMCs, adipocytes and endothelial cells which were treated with serum from JIA patients under sustained remission.

resultsMean duration of the disease was 13.47 ± 5.47 years. Mean age was 25.11 ± 7.21. Time in remission was 3.52 ± 3.33 years. Patients were in remission with no treatment (40%) and with treatments (60%). CVD risk factors and CIMT were similar in JIA patients and controls. However, cholesterol levels were significantly elevated in JIA patients. Levels of adipocytokines, oxidative stress and endothelial activation markers were elevated in serum and PBMCs from JIA patients. Serum of those JIA patients induced the activation of adipocytes, endothelial cells and healthy PBMCs.

conclusionsJIA adult patients in remission have subclinical signs of inflammation and CVD risk, showed by an increase in the levels of inflammatory cytokines, endothelial activation and oxidative stress markers and adipokines, molecules closely involved in the alteration of the vascular system.

Indexed as

Arthritis, JuvenileInflammationAdultAge of OnsetAsymptomatic DiseasesBiomarkersCarotid Intima-Media ThicknessCross-Sectional StudiesCytokinesEndothelium, VascularFemaleHeart Disease Risk FactorsHumansInflammation MediatorsInsulin ResistanceMaleBiomarkersCytokinesInflammation MediatorsCardiovascular riskClinical remissionJuvenile idiopathic arthritis

Identifiers

PMID32665015
PMCPMC7362625
OpenAlexW3043168273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.